MedEvidence Articles
In this episode, we look at the need for cheap, accurate screening tools for common diseases. To that end, we take the example of fatty liver disease. We review the "gold standard" diagnostic tool, liver biopsy, and why that shouldn't be the first line of detection for a fatty liver. We review some standard methods of screening before diving into transient elastography, also known as FibroScan. We look at what this method is, why it may be preferable to an MRI or CT scan, and how clinical researchers use transient elastography in trials. Share with a friend. Rate, Review, and Subscribe to MedEvidence! Articles to be notified when new episodes are released. Follow us on Social Media: Facebook [https://www.facebook.com/MedEvidence] Instagram [https://www.instagram.com/med_evidence/] Twitter [https://x.com/Med_Evidence] LinkedIn [https://www.linkedin.com/company/medevidence] Tiktok [https://www.tiktok.com/@medevidence.com] Youtube [https://youtube.com/@MedEvidence] For more great content, including discussions by physicians and clinical research experts, check out the MedEvidence! Podcast and MedEvidence.com [https://medevidence.com/] Thank you for listening!
119 jaksot
Kommentit
0Ole ensimmäinen kommentoija
Rekisteröidy nyt ja liity MedEvidence Articles-yhteisöön!